Nuwiq, Human cell line recombinant human factor VIII (Human-cl rhFVIII) 4000 IU powder and solvent for solution for injection. Vial of powder and prefilled WFI syringe

Страна: Австралія

мова: англійська

Джерело: Department of Health (Therapeutic Goods Administration)

Активний інгредієнт:

simoctocog alfa, Quantity: 4000 IU

Доступна з:

Octapharma Australia Pty Ltd

Фармацевтична форма:

Injection, powder for

Склад:

Excipient Ingredients: poloxamer; arginine hydrochloride; sucrose; sodium chloride; sodium citrate dihydrate; calcium chloride dihydrate

Адміністрація маршрут:

Intravenous

Одиниць в упаковці:

1 vial

Тип рецепту:

exempt from scheduling - Appendix A; prescription medicine

Терапевтичні свідчення:

Treatment and prophylaxis of bleeding (also during and after surgery) in previously treated paediatric (>= 2 years) and adult patients with haemophilia A (congenital factor VIII deficiency). Nuwiq does not contain von Willebrand Factor and is thus not indicated to treat von Willebrand?s Disease.

Огляд продуктів:

Visual Identification: Nuwiq - white to off-white lyophilised powder,WFI - clear, colourless liquid; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Статус Авторизація:

Registered

Дата Авторизація:

2020-11-12